New Chemotherapy for Childhood Acute Lymphoblastic Leukemia Patients
The FDA recently approved a new anticancer therapeutic for treating patients with childhood acute lymphoblastic leukemia (ALL).
The FDA recently approved a new anticancer therapeutic for treating patients with childhood acute lymphoblastic leukemia (ALL).
The FDA approved the first of a new class of immunotherapy known as CAR T-cell therapy for treating patients with acute lymphoblastic leukemia.